Poland – Solar installation – Zaprojektowanie i wykonanie instalacji fotowoltaicznych na dachach budynków mieszkalnych: przy ul. Kłobuckiej 14, ul. Kłobuckiej 16A/18B, ul. Kłobuckiej 18C, ul. Kłobuckiej 16B/18D, należących do zasobu lokalowego Dzielnicy Ursynów w Warszawie

Poland – Electricity, heating, solar and nuclear energy – Świecka Grupa Zakupowa. Dostawa energii elektrycznej w okresie od 01.01.2027r. do 31.12.2027r.

Poland – Gaseous fuels – Kompleksowa dostawa paliwa gazowego w 2027 r.

Poland – Solar installation – Budowa instalacji odnawialnych źródeł energii na terenie Gmin Nadwiślańskiego Klastra Energii

Poland – Heating oil – Dostawy oleju opałowego.

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Measurable reduction in the costs of deep renovation compared to current best practices; Measurable increase in resource and energy efficiency compared to current best practices; Measurable reduction in the number of days when occupants are disturbed due to renovation works; Measurable reduction of dust, noise, waste and pollutant and greenhouse emissions on the construction site compared to current best practices. Scope: Meeting Europe’s ambition for the renovation of the housing stock requires innovative approaches that improve buildings’ energy performance and occupants’ satisfaction, at a reduced cost while speeding up the renovation process and minimising impact on the construction site and disturbance for occupants. Renovation approaches should cover the whole workflow from design, off-site manufacturing and on-site installation to strategies for maintenance, operation and end of life. Proposals are expected to address all of the following: Demonstrate cost-effective approaches (comprising design, planning and construction processes and techniques) for deep renovation to…

UK registered organisations can apply for a share of up to £150 million. The funding will be to develop, deploy and operate innovative clean maritime solutions for three years in a real world environment. This funding is from the Department for Transport.

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that employ mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally

Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots. There are two funding opportunities per year that are open to all targets.